CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-01-05 | KAITIN KENNETH I Director | Grant or award · Non-qualified stock option (right to buy) | +50,000 | 25,000 | ||
| 2012-01-05 | TOBIN JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +50,000 | 25,000 | ||
| 2012-01-05 | MCNAB JAMES R Director | Grant or award · Non-qualified stock option (right to buy) | +170,000 | 85,000 | ||
| 2012-01-05 | Martell Robert Director | Grant or award · Non-qualified stock option (right to buy) | +50,000 | 25,000 | ||
| 2011-12-23 | BAYH SUSAN B Director | Option exercise | +18,750 | $1.50 | $28K | 43,750 |
| 2011-12-23 | BAYH SUSAN B Director | Option exercise | +10,955 | $2.43 | $27K | 54,705 |
| 2011-12-23 | BAYH SUSAN B Director | Sale | −29,705 | $4.50 | $134K | 25,000 |
| 2011-12-23 | BAYH SUSAN B Director | Option exercise · Non-qualified stock options (right to buy) | −18,750 | $1.50 | $28K | 0 |
| 2011-12-23 | BAYH SUSAN B Director | Option exercise · Non-qualified stock options (right to buy) | −10,955 | $2.43 | $27K | 0 |
| 2011-11-08 | Voi Maurizio Chief Medical Officer | Grant or award · Non-qualified stock option (right to buy) | +243,620 | 243,620 | ||
| 2011-11-08 | Voi Maurizio Chief Medical Officer | Grant or award · Qualified stock option (right to buy) | +106,380 | 350,000 | ||
| 2011-09-14 | Martell Robert Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-05-11 | KAITIN KENNETH I Director | Purchase | +6,800 | $3.68 | $25K | 26,800 |
| 2011-03-31 | MCNAB JAMES R Director | Sale | −25,000 | $3.25 | $81K | 1,122,188 |
| 2011-03-31 | PASSERI DANIEL R CEO and Director | Option exercise | +98,100 | $3.13 | $307K | 163,100 |
| 2011-03-31 | PASSERI DANIEL R CEO and Director | Sale | −98,100 | $3.25 | $319K | 65,000 |
| 2011-03-31 | PASSERI DANIEL R CEO and Director | Option exercise · Non-qualified stock option | −98,100 | $3.13 | $307K | 0 |
| 2011-03-30 | PASSERI DANIEL R CEO and Director | Option exercise | +26,900 | $3.13 | $84K | 91,900 |
| 2011-03-30 | PASSERI DANIEL R CEO and Director | Sale | −26,900 | $3.27 | $88K | 65,000 |
| 2011-03-30 | PASSERI DANIEL R CEO and Director | Option exercise · Qualified stock option | −15,631 | $3.13 | $49K | 0 |
Page 21 of 29 · 564 trades